Sensor-Augmented Insulin Delivery Adds Benefit – AHRQ Analysis
This article was originally published in The Gray Sheet
Executive Summary
Insulin infusion therapy augmented with continuous glucose monitoring for type-1 diabetics received a measure of support in a draft government comparative effectiveness analysis, but more research is needed, the Aug. 15 Agency for Healthcare Research and Quality report concludes.